Patterns of primary care and mortality among patients with schizophrenia or diabetes: A cluster analysis approach to the retrospective study of healthcare utilization

Laurel A. Copeland, John E. Zeber, Chen-pin Wang, Michael L. Parchman, Valerie A. Lawrence, Marcia Valenstein, Alexander L Miller

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background. Patients with schizophrenia have difficulty managing their medical healthcare needs, possibly resulting in delayed treatment and poor outcomes. We analyzed whether patients reduced primary care use over time, differentially by diagnosis with schizophrenia, diabetes, or both schizophrenia and diabetes. We also assessed whether such patterns of primary care use were a significant predictor of mortality over a 4-year period. Methods. The Veterans Healthcare Administration (VA) is the largest integrated healthcare system in the United States. Administrative extracts of the VA's all-electronic medical records were studied. Patients over age 50 and diagnosed with schizophrenia in 2002 were age-matched 1:4 to diabetes patients. All patients were followed through 2005. Cluster analysis explored trajectories of primary care use. Proportional hazards regression modelled the impact of these primary care utilization trajectories on survival, controlling for demographic and clinical covariates. Results. Patients comprised three diagnostic groups: diabetes only (n = 188,332), schizophrenia only (n = 40,109), and schizophrenia with diabetes (Scz-DM, n = 13,025). Cluster analysis revealed four distinct trajectories of primary care use: consistent over time, increasing over time, high and decreasing, low and decreasing. Patients with schizophrenia only were likely to have low-decreasing use (73% schizophrenia-only vs 54% Scz-DM vs 52% diabetes). Increasing use was least common among schizophrenia patients (4% vs 8% Scz-DM vs 7% diabetes) and was associated with improved survival. Low-decreasing primary care, compared to consistent use, was associated with shorter survival controlling for demographics and case-mix. The observational study was limited by reliance on administrative data. Conclusion. Regular primary care and high levels of primary care were associated with better survival for patients with chronic illness, whether psychiatric or medical. For schizophrenia patients, with or without comorbid diabetes, primary care offers a survival benefit, suggesting that innovations in treatment retention targeting at-risk groups can offer significant promise of improving outcomes.

Original languageEnglish (US)
Article number127
JournalBMC Health Services Research
Volume9
DOIs
StatePublished - 2009

Fingerprint

Cluster Analysis
Primary Health Care
Schizophrenia
Retrospective Studies
Delivery of Health Care
Mortality
Survival
Demography
United States Department of Veterans Affairs
Electronic Health Records
Diagnosis-Related Groups
Observational Studies
Psychiatry
Chronic Disease

ASJC Scopus subject areas

  • Health Policy

Cite this

Patterns of primary care and mortality among patients with schizophrenia or diabetes : A cluster analysis approach to the retrospective study of healthcare utilization. / Copeland, Laurel A.; Zeber, John E.; Wang, Chen-pin; Parchman, Michael L.; Lawrence, Valerie A.; Valenstein, Marcia; Miller, Alexander L.

In: BMC Health Services Research, Vol. 9, 127, 2009.

Research output: Contribution to journalArticle

Copeland, Laurel A. ; Zeber, John E. ; Wang, Chen-pin ; Parchman, Michael L. ; Lawrence, Valerie A. ; Valenstein, Marcia ; Miller, Alexander L. / Patterns of primary care and mortality among patients with schizophrenia or diabetes : A cluster analysis approach to the retrospective study of healthcare utilization. In: BMC Health Services Research. 2009 ; Vol. 9.
@article{fc7cec122cd6466ba82f10058ce8a8f3,
title = "Patterns of primary care and mortality among patients with schizophrenia or diabetes: A cluster analysis approach to the retrospective study of healthcare utilization",
abstract = "Background. Patients with schizophrenia have difficulty managing their medical healthcare needs, possibly resulting in delayed treatment and poor outcomes. We analyzed whether patients reduced primary care use over time, differentially by diagnosis with schizophrenia, diabetes, or both schizophrenia and diabetes. We also assessed whether such patterns of primary care use were a significant predictor of mortality over a 4-year period. Methods. The Veterans Healthcare Administration (VA) is the largest integrated healthcare system in the United States. Administrative extracts of the VA's all-electronic medical records were studied. Patients over age 50 and diagnosed with schizophrenia in 2002 were age-matched 1:4 to diabetes patients. All patients were followed through 2005. Cluster analysis explored trajectories of primary care use. Proportional hazards regression modelled the impact of these primary care utilization trajectories on survival, controlling for demographic and clinical covariates. Results. Patients comprised three diagnostic groups: diabetes only (n = 188,332), schizophrenia only (n = 40,109), and schizophrenia with diabetes (Scz-DM, n = 13,025). Cluster analysis revealed four distinct trajectories of primary care use: consistent over time, increasing over time, high and decreasing, low and decreasing. Patients with schizophrenia only were likely to have low-decreasing use (73{\%} schizophrenia-only vs 54{\%} Scz-DM vs 52{\%} diabetes). Increasing use was least common among schizophrenia patients (4{\%} vs 8{\%} Scz-DM vs 7{\%} diabetes) and was associated with improved survival. Low-decreasing primary care, compared to consistent use, was associated with shorter survival controlling for demographics and case-mix. The observational study was limited by reliance on administrative data. Conclusion. Regular primary care and high levels of primary care were associated with better survival for patients with chronic illness, whether psychiatric or medical. For schizophrenia patients, with or without comorbid diabetes, primary care offers a survival benefit, suggesting that innovations in treatment retention targeting at-risk groups can offer significant promise of improving outcomes.",
author = "Copeland, {Laurel A.} and Zeber, {John E.} and Chen-pin Wang and Parchman, {Michael L.} and Lawrence, {Valerie A.} and Marcia Valenstein and Miller, {Alexander L}",
year = "2009",
doi = "10.1186/1472-6963-9-127",
language = "English (US)",
volume = "9",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Patterns of primary care and mortality among patients with schizophrenia or diabetes

T2 - A cluster analysis approach to the retrospective study of healthcare utilization

AU - Copeland, Laurel A.

AU - Zeber, John E.

AU - Wang, Chen-pin

AU - Parchman, Michael L.

AU - Lawrence, Valerie A.

AU - Valenstein, Marcia

AU - Miller, Alexander L

PY - 2009

Y1 - 2009

N2 - Background. Patients with schizophrenia have difficulty managing their medical healthcare needs, possibly resulting in delayed treatment and poor outcomes. We analyzed whether patients reduced primary care use over time, differentially by diagnosis with schizophrenia, diabetes, or both schizophrenia and diabetes. We also assessed whether such patterns of primary care use were a significant predictor of mortality over a 4-year period. Methods. The Veterans Healthcare Administration (VA) is the largest integrated healthcare system in the United States. Administrative extracts of the VA's all-electronic medical records were studied. Patients over age 50 and diagnosed with schizophrenia in 2002 were age-matched 1:4 to diabetes patients. All patients were followed through 2005. Cluster analysis explored trajectories of primary care use. Proportional hazards regression modelled the impact of these primary care utilization trajectories on survival, controlling for demographic and clinical covariates. Results. Patients comprised three diagnostic groups: diabetes only (n = 188,332), schizophrenia only (n = 40,109), and schizophrenia with diabetes (Scz-DM, n = 13,025). Cluster analysis revealed four distinct trajectories of primary care use: consistent over time, increasing over time, high and decreasing, low and decreasing. Patients with schizophrenia only were likely to have low-decreasing use (73% schizophrenia-only vs 54% Scz-DM vs 52% diabetes). Increasing use was least common among schizophrenia patients (4% vs 8% Scz-DM vs 7% diabetes) and was associated with improved survival. Low-decreasing primary care, compared to consistent use, was associated with shorter survival controlling for demographics and case-mix. The observational study was limited by reliance on administrative data. Conclusion. Regular primary care and high levels of primary care were associated with better survival for patients with chronic illness, whether psychiatric or medical. For schizophrenia patients, with or without comorbid diabetes, primary care offers a survival benefit, suggesting that innovations in treatment retention targeting at-risk groups can offer significant promise of improving outcomes.

AB - Background. Patients with schizophrenia have difficulty managing their medical healthcare needs, possibly resulting in delayed treatment and poor outcomes. We analyzed whether patients reduced primary care use over time, differentially by diagnosis with schizophrenia, diabetes, or both schizophrenia and diabetes. We also assessed whether such patterns of primary care use were a significant predictor of mortality over a 4-year period. Methods. The Veterans Healthcare Administration (VA) is the largest integrated healthcare system in the United States. Administrative extracts of the VA's all-electronic medical records were studied. Patients over age 50 and diagnosed with schizophrenia in 2002 were age-matched 1:4 to diabetes patients. All patients were followed through 2005. Cluster analysis explored trajectories of primary care use. Proportional hazards regression modelled the impact of these primary care utilization trajectories on survival, controlling for demographic and clinical covariates. Results. Patients comprised three diagnostic groups: diabetes only (n = 188,332), schizophrenia only (n = 40,109), and schizophrenia with diabetes (Scz-DM, n = 13,025). Cluster analysis revealed four distinct trajectories of primary care use: consistent over time, increasing over time, high and decreasing, low and decreasing. Patients with schizophrenia only were likely to have low-decreasing use (73% schizophrenia-only vs 54% Scz-DM vs 52% diabetes). Increasing use was least common among schizophrenia patients (4% vs 8% Scz-DM vs 7% diabetes) and was associated with improved survival. Low-decreasing primary care, compared to consistent use, was associated with shorter survival controlling for demographics and case-mix. The observational study was limited by reliance on administrative data. Conclusion. Regular primary care and high levels of primary care were associated with better survival for patients with chronic illness, whether psychiatric or medical. For schizophrenia patients, with or without comorbid diabetes, primary care offers a survival benefit, suggesting that innovations in treatment retention targeting at-risk groups can offer significant promise of improving outcomes.

UR - http://www.scopus.com/inward/record.url?scp=69049100097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69049100097&partnerID=8YFLogxK

U2 - 10.1186/1472-6963-9-127

DO - 10.1186/1472-6963-9-127

M3 - Article

C2 - 19630997

AN - SCOPUS:69049100097

VL - 9

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

M1 - 127

ER -